MedTrace Logo

Non-Invasive Hemoglobin Study

NCT02206399 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 237

Last updated 2016-06-27

No results posted yet for this study

Summary

The investigators clinical trials will be for a medical device that is non-invasive in nature. The investigators will be studying whether their non-invasive medical device gets data that is as good as, or better than, an FDA previously approved, blood analysis device. There is no study hypothesis for this study.

Conditions

Sponsors & Collaborators

  • DRMiller Engineering

    collaborator UNKNOWN

  • Convergence Biometrics

    lead INDUSTRY

Principal Investigators

  • Anne Igbokwe, MD · BloodSource

  • Chris Gresens, MD · BloodSource

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02206399 on ClinicalTrials.gov